The Risk-Benefit Balance in the COVID-19 “Vaccine Hesitancy” Literature: An Umbrella Review Protocol
DOI:
https://doi.org/10.56098/ijvtpr.v2i2.62Keywords:
adverse effects, COVID-19 vaccine, critical policy analysis, risk-benefit analysis, risk-benefit ratio, informed consent, side effects of COVID vaccines, COVID vaccine hesitancy, COVID vaccine safetyAbstract
Background: “Vaccine hesitancy” has been described as a major public health problem, especially in the COVID-19 era. Identified factors driving “hesitancy” include the concerns of recipients with the safety, side effects, and risk-benefit ratio of COVID-19 vaccines[1] — a proper assessment and disclosure of which are critical to the requisite process of informed consent. However, the expert literature has given little attention to the evidence informing these concerns, focusing instead on features of the recipients themselves to explain the phenomenon of so-called “hesitancy”.
Goal: This umbrella review will expand the scope of research on “vaccine hesitancy” by examining how the safety, side effects, and risk-benefit ratio concerns of recipients of COVID-19 vaccines are addressed in the expert literature.
Inclusion criteria: We will include systematic reviews on COVID-19 “vaccine hesitancy” that examine hesitancy in any population involved with COVID-19 vaccination decisions for themselves or as caretakers (e.g., decisions about “vaccinating” their children) to capture the broadest possible range of perspectives on the phenomenon of interest. Only completed, published, and refereed systematic reviews in English will be included.
Methods: We will search PubMed, the Epistemonokos COVID-19 platform (COVID-19 L·OVE), and the WHO Global Research on COVID-19 Database to locate quantitative, qualitative, and mixed methods studies reviews. Reviews that meet the inclusion criteria will undergo quality assessment (AMSTAR) and data extraction. Two reviewers will independently conduct title and abstract screening and extract and synthesize the data. Disagreements will be resolved through full team discussion. Subgroup analyses will be performed to compare findings according to social indicators of target populations, country location of the first author, and other contextual factors. Thematic analysis and synthesis will be used to “transform the data” into themes by applying a deductive-inductive approach. Frequency distributions will be calculated to assess the strength of support for each theme. Findings will be presented in tabular and narrative forms to facilitate their interpretation.
Significance: Informed consent is a fundamental bioethical principle in medical research and practice. Insufficient attention to the concerns of vaccine recipients about these matters, compounded by a neglect to discuss the evidence-base informing these concerns, may contribute to the very problem that the COVID-19 “vaccine hesitancy” expert literature purports to address. This is especially true of an intervention based on novel technologies and intended to be delivered on a global scale. Identifying if and how the expert literature engages with these concerns is critical.
Systematic review registration: PROSPERO CRD42022351489.
[1] Although we use the phrase “COVID-19 vaccines” throughout, we believe they should more appropriately be referred to as “COVID-19 genetic vaccines”, “COVID-19 injections”, or "mRNA biologicals”. However, we have chosen “vaccine” with no quotation marks for better readability. For an in-depth discussion of this issue, see Rose (2021).
References
Abba-Aji, M., Stuckler, D., Galea, S., & McKee, M. (2022). Ethnic/racial minorities’ and migrants’ access to COVID-19 vaccines: A systematic review of barriers and facilitators. J Migr Health, 5, 100086—100086. MEDLINE. https://doi.org/10.1016/j.jmh.2022.100086
Acharya, C. B., Schrom, J., Mitchell, A. M., Coil, D. A., Marquez, C., Rojas, S., Wang, C. Y., Liu, J., Pilarowski, G., Solis, L., Georgian, E., Belafsky, S., Petersen, M., DeRisi, J., Michelmore, R., & Havlir, D. (2022). Viral load among vaccinated and unvaccinated, asymptomatic and symptomatic persons infected with the SARS-CoV-2 Delta variant. Open Forum Infectious Diseases, 9(5), ofac135. https://doi.org/10.1093/ofid/ofac135
AMSTAR. (n.d.). Assessing the Methodological Quality of Systematic Reviews. Retrieved October 12, 2022, from https://amstar.ca/About_Amstar.php
Anakpo, G., & Mishi, S. (2022). Hesitancy of COVID-19 vaccines: rapid systematic review of the measurement, predictors, and preventive strategies. Human Vaccines & Immunotherapeutics, 2074716. https://doi.org/10.1080/21645515.2022.2074716
Bacchi, C. (2012). Why study problematizations? making politics visible. Open Journal of Political Science, 02(01), 1—8. https://doi.org/10.4236/ojps.2012.21001
Batteux, E., Mills, F., Jones, L. F., Symons, C., & Weston, D. (2022). The effectiveness of interventions for increasing COVID-19 vaccine uptake: a systematic review. Vaccines, 10(3). https://doi.org/10.3390/vaccines10030386
Blumenthal, K. G., Robinson, L. B., Camargo, C. A., Jr, Shenoy, E. S., Banerji, A., Landman, A. B., & Wickner, P. (2021). Acute allergic reactions to mRNA COVID-19 vaccines. JAMA, 325(15), 1562—1565. https://doi.org/10.1001/jama.2021.3976
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77—101. https://doi.org/10.1191/1478088706qp063oa
Broudy, D. (2021). Vaccine development and social control: A psychopathology of impaired reasoning in the global push for mass compliance. International Journal of Vaccine Theory, Practice, and Research, 2(1), 93–124. https://doi.org/10.56098/ijvtpr.v2i1.29
Bruder, M., Haffke, P., Neave, N., Nouripanah, N., & Imhoff, R. (2013). Measuring individual differences in generic beliefs in conspiracy theories across cultures: Conspiracy Mentality Questionnaire. Frontiers in Psychology, 4. https://doi.org/10.3389/fpsyg.2013.00225
Català, A., Muñoz-Santos, C., Galván-Casas, C., Roncero Riesco, M., Revilla Nebreda, D., Solá-Truyols, A., Giavedoni, P., Llamas-Velasco, M., González-Cruz, C., Cubiró, X., Ruíz-Villaverde, R., Gómez-Armayones, S., Gil Mateo, M. p., Pesqué, D., Marcantonio, O., Fernández-Nieto, D., Romaní, J., Iglesias Pena, N., Carnero Gonzalez, L., … Guilabert, A. (2022). Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases*. British Journal of Dermatology, 186(1), 142—152. https://doi.org/10.1111/bjd.20639
Chow, K. W., Pham, N. V., Ibrahim, B. M., Hong, K., & Saab, S. (2022). Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: A Systematic Review of the Literature. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-022-07504-w
Classen, J. B. (2021). US COVID-19 Vaccines Proven to Cause More Harm than Good Based on Pivotal Clinical Trial Data Analyzed Using the Proper Scientific Endpoint, “All Cause Severe Morbidity.” 6. https://www.scivisionpub.com/abstract-display.php?id=1811
Doshi, P., Godlee, F., & Abbasi, K. (2022). COVID-19 vaccines and treatments: we must have raw data, now. BMJ, o102. https://doi.org/10.1136/bmj.o102
Fisman, D. N., Amoako, A., & Tuite, A. R. (2022). Impact of population mixing between vaccinated and unvaccinated subpopulations on infectious disease dynamics: implications for SARS-CoV-2 transmission. CMAJ, 194(16), E573—E580. https://doi.org/10.1503/cmaj.212105
Fraiman, J., Erviti, J., Jones, M., Greenland, S., Whelan, P., Kaplan, R. M., & Doshi, P. (2022). Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults. Vaccine. https://doi.org/10.1016/j.vaccine.2022.08.036
Goffman, E. (2009). Stigma: Notes on the Management of Spoiled Identity. Simon and Schuster.
Guyatt, G. H., Sackett, D. L., Sinclair, J. C., Hayward, R., Cook, D. J., Cook, R. J., Bass, E., Gerstein, H., Haynes, B., Holbrook, A., Jaeschke, R., Laupacls, A., Moyer, V., & Wilson, M. (1995). Users’ Guides to the Medical Literature: IX. a method for grading health care recommendations. JAMA, 274(22), 1800—1804. https://doi.org/10.1001/jama.1995.03530220066035
Hammond, J., Leister-Tebbe, H., Gardner, A., Abreu, P., Bao, W., Wisemandle, W., Baniecki, M., Hendrick, V. M., Damle, B., Simón-Campos, A., Pypstra, R., & Rusnak, J. M. (2022). Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19. New England Journal of Medicine, 386(15), 1397—1408. https://doi.org/10.1056/NEJMoa2118542
Hoffmann, M., Krüger, N., Schulz, S., Cossmann, A., Rocha, C., Kempf, A., Nehlmeier, I., Graichen, L., Moldenhauer, A.-S., Winkler, M. S., Lier, M., Dopfer-Jablonka, A., Jäck, H.-M., Behrens, G. M. N., & Pöhlmann, S. (2022). The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic. Cell, 185(3), 447-456.e11. https://doi.org/10.1016/j.cell.2021.12.032
Hudson, A., & Montelpare, W. J. (2021). Predictors of vaccine hesitancy: implications for COVID-19 public health messaging. International Journal of Environmental Research and Public Health, 18(15), 8054. https://doi.org/10.3390/ijerph18158054
Ioannidis, J. P. A. (2022). The end of the COVID-19 pandemic. European Journal of Clinical Investigation, 52(6), e13782. https://doi.org/10.1111/eci.13782
Khairat, S., Zou, B., & Adler-Milstein, J. (2022). Factors and reasons associated with low COVID-19 vaccine uptake among highly hesitant communities in the US. American Journal of Infection Control, 50(3), 262-267. https://doi.org/10.1016/j.ajic.2021.12.013
Ledford, C. J. W., Cafferty, L. A., Moore, J. X., Roberts, C., Whisenant, E. B., Garcia Rychtarikova, A., & Seehusen, D. A. (2022). The dynamics of trust and communication in COVID-19 vaccine decision making: a qualitative inquiry. Journal of Health Communication, 27(1), 17—26. https://doi.org/10.1080/10810730.2022.2028943
Light, D. W., Lexchin, J., & Darrow, J. J. (2013). Institutional corruption of pharmaceuticals and the myth of safe and effective drugs. Journal of Law, Medicine & Ethics, 41(3), 590—600. https://doi.org/10.1111/jlme.12068
Malhotra, A. (2022a). Curing the pandemic of misinformation on COVID-19 mRNA vaccines through real evidence-based medicine—Part 1. Journal of Insulin Resistance, 5(1), Article 1. https://doi.org/10.4102/jir.v5i1.71
Malhotra, A. (2022b). Curing the pandemic of misinformation on COVID-19 mRNA vaccines through real evidence-based medicine—Part 2. Journal of Insulin Resistance, 5(1), Article 1. https://doi.org/10.4102/jir.v5i1.72
Mansanguan, S., Charunwatthana, P., Piyaphanee, W., Dechkhajorn, W., Poolcharoen, A., & Mansanguan, C. (2022). Cardiovascular manifestation of the BNT162b2 mRNA COVID-19 vaccine in adolescents. Tropical Medicine and Infectious Disease, 19 Aug 2022, 7(8):196 https://europepmc.org/article/MED/36006288
Matić, Z., & Šantak, M. (2022). Current view on novel vaccine technologies to combat human infectious diseases. Applied Microbiology and Biotechnology, 106(1), 25—56. https://doi.org/10.1007/s00253-021-11713-0
Mena, G. E., Martinez, P. P., Mahmud, A. S., Marquet, P. A., Buckee, C. O., & Santillana, M. (2021). Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile. Science, 372(6545), eabg5298. https://doi.org/10.1126/science.abg5298
Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, E. J., Nadir, E., Olsha-Castell, S., Arad, D., Hasin, T., Levi, N., Asleh, R., Amir, O., Meir, K., Cohen, D., Dichtiar, R., Novick, D., Hershkovitz, Y., Dagan, R., Leitersdorf, I., Alroy-Preis, S. (2021). Myocarditis after BNT162b2 mRNA vaccine against COVID-19 in Israel. New England Journal of Medicine, 385(23), 2140—2149. https://doi.org/10.1056/NEJMoa2109730
Mills, E., Jadad, A. R., Ross, C., & Wilson, K. (2005). Systematic review of qualitative studies exploring parental beliefs and attitudes toward childhood vaccination identifies common barriers to vaccination. Journal of Clinical Epidemiology, 58(11), 1081—1088. https://doi.org/10.1016/j.jclinepi.2005.09.002
Momplaisir, F., Haynes, N., Nkwihoreze, H., Nelson, M., Werner, R. M., & Jemmott, J. (2021). Understanding drivers of coronavirus disease 2019 vaccine hesitancy among blacks. Clinical Infectious Diseases, 73(10), 1784—1789. https://doi.org/10.1093/cid/ciab102
New York State Department of Health. (n.d.). The Science Behind Vaccine Research and Testing. 2014. Retrieved October 12, 2022, from https://www.health.ny.gov/prevention/immunization/vaccine_safety/science.htm
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, n71. https://doi.org/10.1136/bmj.n71
Park, H. K., Ham, J. H., Jang, D. H., Lee, J. Y., & Jang, W. M. (2021). Political Ideologies, Government Trust, and COVID-19 vaccine hesitancy in South Korea: a cross-sectional survey. International Journal of Environmental Research and Public Health, 18(20), Article 20. https://doi.org/10.3390/ijerph182010655
Pluye, P., & Hong, Q. N. (2014). Combining the power of stories and the power of numbers: mixed methods research and mixed studies reviews. Annual Review of Public Health, 35(1), 29—45. https://doi.org/10.1146/annurev-publhealth-032013-182440
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., Bailey, R., Swanson, K. A., Roychoudhury, S., Koury, K., Li, P., Kalina, W. V., Cooper, D., Frenck, R. W., Hammitt, L. L., … Gruber, W. C. (2020). Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. New England Journal of Medicine, 383(27), 2603—2615. https://doi.org/10.1056/NEJMoa2034577
Popay, J., Roberts, H., Sowden, A., Petticrew, M., Arai, L., Rodgers, M., & Britten, N. (2006). Guidance on the conduct of narrative synthesis in systematic reviews: A product from the ESRC methods programme. https://doi.org/10.13140/2.1.1018.4643
Ridgway, J. P., Tideman, S., Wright, B., & Robicsek, A. (2022). Rates of COVID-19 Among unvaccinated adults with prior COVID-19. JAMA Network Open, 5(4), e227650. https://doi.org/10.1001/jamanetworkopen.2022.7650
Rose, J. “A Report on the U.S. Vaccine Adverse Events Reporting System (VAERS) of the COVID-1 9 messenger ribonucleic acid (mRNA) biologicals.” Science, Public Health Policy, and the Law, 2 (2021): 59–80. https://www.datascienceassn.org/sites/default/files/VAERS%20Report%20on%20Covid19%20Vaccine%20mRNA%20Biologicals%20-%20May%2C%202021.pdf
SAGE. (2014). Report of the SAGE Working Group on Vaccine Hesitancy. WHO. https://www.asset-scienceinsociety.eu/sites/default/files/sage_working_group_revised_report_vaccine_hesitancy.pdf
Sallam, M. (2021). COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. Vaccines, 9(2), 160. https://doi.org/10.3390/vaccines9020160
Santiago, D. (2022). Playing Russian Roulette with every COVID-19 injection: The deadly global game. International Journal of Vaccine Theory, Practice, and Research, 2(2), 619–650. https://doi.org/10.56098/ijvtpr.v2i2.36
Say, D., Crawford, N., McNab, S., Wurzel, D., Steer, A., & Tosif, S. (2021). Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. The Lancet Child & Adolescent Health, 5(6), e22-e23. https://doi.org/10.1016/S2352-4642(21)00124-3
Seneff, S., & Nigh, G. (2021). Worse than the disease? Reviewing some possible unintended consequences of the mRNA vaccines against COVID-19. International Journal of Vaccine Theory, Practice, and Research, 2(1), 38–79. https://doi.org/10.56098/ijvtpr.v2i1.23
Shea, B. J., Hamel, C., Wells, G. A., Bouter, L. M., Kristjansson, E., Grimshaw, J., Henry, D. A., & Boers, M. (2009). AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. Journal of Clinical Epidemiology, 62(10), 1013—1020. https://doi.org/10.1016/j.jclinepi.2008.10.009
Shuster, E. (1997). Fifty Years Later: The Significance of the Nuremberg Code. New England Journal of Medicine, 337(20), 1436—1440. https://doi.org/10.1056/NEJM199711133372006
Singanayagam, A., Hakki, S., Dunning, J., Madon, K. J., Crone, M. A., Koycheva, A., Derqui-Fernandez, N., Barnett, J. L., Whitfield, M. G., Varro, R., Charlett, A., Kundu, R., Fenn, J., Cutajar, J., Quinn, V., Conibear, E., Barclay, W., Freemont, P. S., Taylor, G. P., … Lackenby, A. (2022). Community transmission and viral load kinetics of the SARS-CoV-2 Delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: A prospective, longitudinal, cohort study. The Lancet Infectious Diseases, 22(2), 183—195. https://doi.org/10.1016/S1473-3099(21)00648-4
Smith, V., Devane, D., Begley, C. M., & Clarke, M. (2011). Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Medical Research Methodology, 11(1), 15. https://doi.org/10.1186/1471-2288-11-15
Subramanian, S. V., & Kumar, A. (2021). Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States. European Journal of Epidemiology. https://doi.org/10.1007/s10654-021-00808-7
Thomas, J., & Harden, A. (2008). Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Medical Research Methodology, 8(1), 45. https://doi.org/10.1186/1471-2288-8-45
Thornley, S., Morris, A. J., Sundborn, G., & Bailey, S. (2022). How fatal is COVID-19 compared with seasonal influenza? The devil is in the detail. https://www.bmj.com/content/371/bmj.m3883/rr
Tiede, A., Sachs, U. J., Czwalinna, A., Werwitzke, S., Bikker, R., Krauss, J. K., Donnerstag, F., Weißenborn, K., Höglinger, G., Maasoumy, B., Wedemeyer, H., & Ganser, A. (2021). Prothrombotic immune thrombocytopenia after COVID-19 vaccination. Blood, 138(4), 350353. https://doi.org/10.1182/blood.2021011958
Tram, K. H., Saeed, S., Bradley, C., Fox, B., Eshun-Wilson, I., Mody, A., & Geng, E. (2021). Deliberation, dissent, and distrust: understanding distinct drivers of coronavirus disease 2019 vaccine hesitancy in the United States. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, ciab633. https://doi.org/10.1093/cid/ciab633
van Mulukom, V., Pummerer, L. J., Alper, S., Bai, H., Čavojová, V., Farias, J., Kay, C. S., Lazarevic, L. B., Lobato, E. J. C., Marinthe, G., Pavela Banai, I., Šrol, J., & Žeželj, I. (2022). Antecedents and consequences of COVID-19 conspiracy beliefs: A systematic review. Social Science & Medicine (1982), 301, 114912. https://doi.org/10.1016/j.socscimed.2022.114912
Wise, J. (2021). COVID-19: Highest death rates seen in countries with most overweight populations. BMJ, n623. https://doi.org/10.1136/bmj.n623
Wise, J. (2022). COVID-19: Symptomatic infection with Omicron variant is milder and shorter than with Delta, study reports. BMJ, 377, o922. https://doi.org/10.1136/bmj.o922
World Health Organization. (2019). Ten health issues WHO will tackle this year. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019
World Health Organization. (2022). Global COVID-19 Vaccination Strategy in a Changing World: July 2022 update. https://www.who.int/publications/m/item/global-covid-19-vaccination-strategy-in-a-changing-world--july-2022-update
World Medical Association. (1964). Declaration of Helsinki. New England Journal of Medicine, 271(9), 473-474. https://www.nejm.org/doi/full/10.1056/NEJM196408272710913
Yamamoto, K. (2022). Adverse effects of COVID-19 vaccines and measures to prevent them. Virology Journal, 19(1), 100. https://doi.org/10.1186/s12985-022-01831-0
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Chaufan Claudia, Natalie Hemsing, Jennifer McDonald, Camila Heredia
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The copyright for materials in this journal, IJVTPR, is owned by the author. The author, however, grants first right of publication to the journal, IJVTPR and assures the editorial staff of the journal that the work submitted has not simultaneously been submitted to any other journal, nor is it under consideration for publication by any other journal. If any portion of the work submitted has appeared elsewhere, the quoted material is properly cited and credit is given to the original publisher. The submitting author (or the principal and corresponding author of the work) also assures the editors of IJVTPR that he or she has obtained all required written permissions from any quoted authors or publishers of quoted materials. The submitting author also agrees to hold IJVTPR and its editorial staff harmless from any infractions of copyright law that may be discovered at any time in the future in the submitted work. The author assures the editorial staff at IJVTPR that none of the work submitted is plagiarized, and that any recycled or precycled material by the author is identified as such with proper credits in the text to any other parties holding a copyright interest in the quoted material.